SCHEMBL10568102

SCHEMBL10568102

COC(=O)c1cn(Cc2c(F)cccc2F)cn1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
GRM2 Q14416 1/20 0.45
RIPK1 Q13546 1/20 0.42
CA5A P35218 1/20 0.42
SCD O00767 1/20 0.39
CYP2C19 P33261 2/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 2/20 0.38
TSHR P16473 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
JAK3 P52333 1/20 0.37
KLKB1 P03952 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10568262 0.87 ALDH1A1 (0.48) CA5AALDH1A1KDM4ELMNAMAPT
SCHEMBL10568691 0.85 KDM5A (0.51) MEN1KMT2AGRM2CYP2C19ALDH1A1
SCHEMBL9714265 0.84 RIPK1 (0.42) RIPK1CA5ASCDCYP2C19JAK2
SCHEMBL12179543 0.83 CA5A (0.46) RIPK1CA5AALDH1A1KDM4EKLKB1
SCHEMBL9714146 0.82 CA5A (0.58) GRM2RIPK1CA5AJAK2JAK1
SCHEMBL9714332 0.82 KLKB1 (0.44) MEN1KMT2ARIPK1CA5ACYP2C19
SCHEMBL9714339 0.82 RIPK1 (0.41) MEN1KMT2ARIPK1CA5ASCD
SCHEMBL9714241 0.79 RIPK1 (0.43) MEN1KMT2ARIPK1CA5ACYP2C19
SCHEMBL30587512 0.79 GRM2 (0.56) MEN1KMT2AGRM2SCDKDM4E
SCHEMBL10570402 0.79 GRM2 (0.56) MEN1KMT2AGRM2SCDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113994970-B Substituted sulfonamides for combating animal pests 拜耳公司 2023-05-12 CN disclosed
CN-113994970-A Substituted sulfonamides for combating animal pests 拜耳公司 2022-02-01 CN disclosed
EP-3534709-B1 SUBSTITUTED SULFONYLAMIDE FOR COMBATING ANIMAL PESTS BAYER AG (DE) 2021-06-16 EP disclosed
EP-3534709-B1 SUBSTITUTED SULFONYLAMIDE FOR COMBATING ANIMAL PESTS BAYER AG (DE) 2021-06-16 EP disclosed
US-10820591-B2 Substituted sulfonyl amides for controlling animal pests BAYER AKTIENGESELLSCHAFT (DE) 2020-11-03 US disclosed
US-10820591-B2 Substituted sulfonyl amides for controlling animal pests BAYER AKTIENGESELLSCHAFT (DE) 2020-11-03 US disclosed
EP-3534709-A1 SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS Bayer Aktiengesellschaft (DE) 2019-09-11 EP disclosed
US-20190269134-A1 SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS BAYER AKTIENGESELLSCHAFT (DE) 2019-09-05 US disclosed
US-20190269134-A1 SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS BAYER AKTIENGESELLSCHAFT (DE) 2019-09-05 US disclosed
CN-110191639-A Substituted sulfonamides for combating animal pests 拜耳公司 2019-08-30 CN disclosed
US-4851424-A 1-Phenyl-lower alkyl-imidazole 4- or 5-carboxamide compounds which are useful in the treatment of epilepsy CIBA-GEIGY CORPORATION (US) 1989-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190269134-A1 SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS MLYCD, STOM, DDT MEN1 878/4885KMT2A 380/4885GRM2 283/4885
US-10820591-B2 Substituted sulfonyl amides for controlling animal pests MLYCD, STOM, DDT MEN1 878/4885KMT2A 380/4885GRM2 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.